Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10341214rdf:typepubmed:Citationlld:pubmed
pubmed-article:10341214lifeskim:mentionsumls-concept:C0044602lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0007603lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0085262lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0040715lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C2936824lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C1522702lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0391551lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C1518792lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0599718lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0599813lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C0599893lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:10341214lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10341214pubmed:dateCreated1999-8-13lld:pubmed
pubmed-article:10341214pubmed:abstractTextADP-ribosylation factors (ARFs) are small GTP-binding proteins that function as regulators of eukaryotic vesicle trafficking. Cytohesin-1 is a member of a family of ARF guanine nucleotide-exchange factors that contain a C-terminal pleckstrin homology (PH) domain which has been proposed to bind the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3). Here we demonstrate that in vitro, recombinant cytohesin-1 binds, via its PH domain, the inositol head group of PIP3, inositol 1,3,4, 5-tetrakisphosphate (IP4), with an affinity greater than 200-fold higher than the inositol head group of either phosphatidylinositol 4, 5-bisphosphate or phosphatidylinositol 3,4-bisphosphate. Moreover, addition of glycerol or diacetylglycerol to the 1-phosphate of IP4 does not alter the ability to interact with cytohesin-1, data which is entirely consistent with cytohesin-1 functioning as a putative PIP3 receptor. To address whether cytohesin-1 binds PIP3 in vivo, we have expressed a chimera of green fluorescent protein (GFP) fused to the N terminus of cytohesin-1 in PC12 cells. Using laser scanning confocal microscopy we demonstrate that either EGF- or NGF-stimulation of transiently transfected PC12 cells results in a rapid translocation of GFP-cytohesin-1 from the cytosol to the plasma membrane. This translocation is dependent on the cytohesin-1 PH domain and occurs with a time course that parallels the rate of plasma membrane PIP3 production. Furthermore, the translocation requires the ability of either agonist to activate PI 3-kinase, since it is inhibited by wortmannin (100 nM), LY294002 (50 microM) and by coexpression with a dominant negative p85. This data therefore suggests that in vivo cytohesin-1 can interact with PIP3 via its PH domain.lld:pubmed
pubmed-article:10341214pubmed:languageenglld:pubmed
pubmed-article:10341214pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:citationSubsetIMlld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10341214pubmed:statusMEDLINElld:pubmed
pubmed-article:10341214pubmed:monthJunlld:pubmed
pubmed-article:10341214pubmed:issn0021-9533lld:pubmed
pubmed-article:10341214pubmed:authorpubmed-author:Venkateswarlu...lld:pubmed
pubmed-article:10341214pubmed:authorpubmed-author:TavaréJ MJMlld:pubmed
pubmed-article:10341214pubmed:authorpubmed-author:CullenP JPJlld:pubmed
pubmed-article:10341214pubmed:authorpubmed-author:Gunn-MooreFFlld:pubmed
pubmed-article:10341214pubmed:issnTypePrintlld:pubmed
pubmed-article:10341214pubmed:volume112 ( Pt 12)lld:pubmed
pubmed-article:10341214pubmed:ownerNLMlld:pubmed
pubmed-article:10341214pubmed:authorsCompleteYlld:pubmed
pubmed-article:10341214pubmed:pagination1957-65lld:pubmed
pubmed-article:10341214pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:meshHeadingpubmed-meshheading:10341214...lld:pubmed
pubmed-article:10341214pubmed:year1999lld:pubmed
pubmed-article:10341214pubmed:articleTitleEGF-and NGF-stimulated translocation of cytohesin-1 to the plasma membrane of PC12 cells requires PI 3-kinase activation and a functional cytohesin-1 PH domain.lld:pubmed
pubmed-article:10341214pubmed:affiliationDepartment of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK.lld:pubmed
pubmed-article:10341214pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10341214pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1942entrezgene:pubmedpubmed-article:10341214lld:entrezgene
entrez-gene:9267entrezgene:pubmedpubmed-article:10341214lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10341214lld:pubmed